- List
- By Topic
- On Map
- Search Details

"Adrenal Hyperplasia, Congenital" [DISEASE]
Need help? See RSS Feeds
Choose a feed type:

"Adrenal Hyperplasia, Congenital" [DISEASE] (86 records)
Need help? See Downloading Content for Analysis
For Advanced Users: Full Study Record XML Download
1 | NCT01771328 | Recruiting | Continuous Subcutaneous Hydrocortisone Infusion in Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
20 | All | 18 Years to 60 Years (Adult) | NCT01771328 | 2012/749 | CAH | February 2013 | January 2017 | January 2017 | January 18, 2013 | December 21, 2016 |
|
|
2 | NCT03162172 | Completed | Growth Hormone (GH) in Congenital Adrenal Hyperplasia |
|
Observational |
|
Other |
|
|
25 | All | 18 Years to 50 Years (Adult) | NCT03162172 | CIC 2009-019 | OPALE GH | September 15, 2015 | March 15, 2016 | March 15, 2016 | May 22, 2017 | May 22, 2017 |
|
|||
3 | NCT00694525 | Unknown † | Role of the Protein Osteoprotegerin in the Bone Health of Women With Congenital Adrenal Hyperplasia |
|
Observational |
|
NIH |
|
|
40 | Female | 20 Years to 35 Years (Adult) | NCT00694525 | RDCRN 5611 | April 2008 | June 2009 | June 2009 | June 10, 2008 | June 2, 2009 |
|
||||
4 | NCT00529841 | Completed | Research Study for Children With Salt Wasting Congenital Adrenal Hyperplasia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
7 | All | 3 Years to 18 Years (Child, Adult) | NCT00529841 | H-19704 GCRC # 0962 |
January 2007 | September 2008 | September 2008 | September 14, 2007 | September 14, 2015 |
|
||
5 | NCT00617292 | Unknown † | Determining the Long-Term Effects of Prenatal Dexamethasone Treatment in Children With 21-Hydroxylase Deficiency and Their Mothers |
|
Observational |
|
NIH |
|
|
233 | All | 12 Years and older (Child, Adult, Senior) | NCT00617292 | RDCRN 5610 | January 2008 | July 2009 | July 2009 | February 18, 2008 | December 9, 2008 |
|
||||
6 | NCT00542841 | Completed | Examining Genetic Differences Among People With 21-Hydroxylase Deficiency |
|
|
Interventional | Not Applicable |
|
Other / NIH |
|
|
99 | All | 18 Years to 50 Years (Adult) | NCT00542841 | RDCRN 5607 U54RR019484 RR019484 |
August 2007 | March 2009 | March 2009 | October 12, 2007 | December 14, 2015 |
|
||
7 | NCT00621985 | Completed Has Results |
Dexamethasone Treatment of Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 2 |
|
Other |
|
|
5 | All | 2 Years to 9 Years (Child) | NCT00621985 | 08-01-0025 | April 2008 | June 2009 | June 2009 | February 22, 2008 | February 23, 2011 | February 23, 2011 |
|
|
8 | NCT01862380 | Active, not recruiting | Adrenocortical Functions in Women With Nonclassical 21-hydroxylase Deficiency. |
|
|
Interventional | Not Applicable |
|
Other |
|
|
41 | Female | 18 Years to 50 Years (Adult) | NCT01862380 | P111005 | EVAF-21 | February 2013 | December 2015 | November 2016 | May 24, 2013 | September 29, 2016 |
|
|
9 | NCT01495910 | Completed | A Study Examining Doses of Abiraterone Acetate in Adult Women With 21-Hydroxylase Deficiency |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
6 | Female | 18 Years and older (Adult, Senior) | NCT01495910 | CR100007 212082HPL1002 |
December 2011 | February 2013 | February 2013 | December 20, 2011 | February 28, 2014 |
|
||
10 | NCT02804178 | Completed | A Study of ATR-101 for the Treatment of Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
15 | All | 18 Years to 80 Years (Adult, Senior) | NCT02804178 | ATR-101-201 | May 18, 2016 | August 17, 2017 | August 17, 2017 | June 17, 2016 | March 21, 2018 |
|
||
11 | NCT01807364 | Completed | Cardiovascular Risk Profile in Patients With Congenital Adrenal Hyperplasia |
|
Observational |
|
Other |
|
|
170 | All | 18 Years and older (Adult, Senior) | NCT01807364 | AOR 10032 P091106 |
cardiohcs | May 2011 | September 2015 | April 2016 | March 8, 2013 | June 17, 2016 |
|
|||
12 | NCT02349503 | Withdrawn | Safety, Pharmacokinetics and Pharmacodynamics of NBI-77860 in Adolescent Females With Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
0 | Female | 12 Years to 18 Years (Child, Adult) | NCT02349503 | NBI-77860-1401 | February 2015 | October 2015 | October 2015 | January 29, 2015 | June 11, 2015 |
|
||
13 | NCT03162159 | Recruiting | Adult Height Prediction in Congenital Adrenal Hyperplasia |
|
|
Observational |
|
Other |
|
|
600 | All | 18 Years to 40 Years (Adult) | NCT03162159 | CE-CIC-GREN-09-19 | OPALE Model | September 2010 | December 2014 | December 2018 | May 22, 2017 | May 22, 2017 |
|
||
14 | NCT02552251 | Unknown † | COrticosteroid in Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 2 Phase 3 |
|
Other |
|
|
40 | Female | 18 Years to 55 Years (Adult) | NCT02552251 | 11-059 | COCA | August 2012 | December 2015 | September 17, 2015 | September 17, 2015 |
|
||
15 | NCT00749593 | Completed | Study of UK Adults With Congenital Adrenal Hyperplasia. |
|
Observational |
|
Other |
|
|
25 | All | 18 Years to 65 Years (Adult) | NCT00749593 | CaHASE STH13503 MREC 04/07/013 |
CaHASE | August 2004 | June 2007 | December 2011 | September 9, 2008 | June 11, 2012 |
|
|||
16 | NCT03257462 | Recruiting | Study of SPR001 in Adults With Classic Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 2 |
|
Industry |
|
|
18 | All | 18 Years and older (Adult, Senior) | NCT03257462 | SPR001-201 | July 26, 2017 | June 2018 | July 2018 | August 22, 2017 | October 17, 2017 |
|
||
17 | NCT02574910 | Recruiting | Androgen Reduction in Congenital Adrenal Hyperplasia, Phase 1 |
|
|
Interventional | Phase 1 |
|
Other / NIH |
|
|
36 | All | 2 Years to 9 Years (Child) | NCT02574910 | 112014-087 1U01HD083493-01 |
August 1, 2017 | August 2018 | September 2018 | October 14, 2015 | August 4, 2017 |
|
||
18 | NCT02716818 | Recruiting | Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
110 | All | 18 Years and older (Adult, Senior) | NCT02716818 | DIUR-005 | February 22, 2016 | April 2018 | April 2018 | March 23, 2016 | July 17, 2017 |
|
||
19 | NCT00559078 | Completed | Qualitative Research on Women With Congenital Adrenal Hyperplasia |
|
|
Observational |
|
Other |
|
|
16 | Female | 25 Years to 55 Years (Adult) | NCT00559078 | 1-Malouf | CAH | July 2007 | May 2009 | November 16, 2007 | November 9, 2009 |
|
|||
20 | NCT00151710 | Completed | Effects of Pioglitazone in Congenital Adrenal Hyperplasia |
|
|
Interventional | Not Applicable |
|
Other |
|
All | 18 Years and older (Adult, Senior) | NCT00151710 | H6E-UT-O013 | September 9, 2005 | March 1, 2007 |
|
|||||||
21 | NCT02096510 | Recruiting | Ultradian Subcutaneous Hydrocortisone Infusion in Addison Disease and Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 1 Phase 2 |
|
Other |
|
|
10 | All | 18 Years to 65 Years (Adult) | NCT02096510 | 2013/1738 | August 2014 | December 2017 | December 2017 | March 26, 2014 | December 21, 2016 |
|
||
22 | NCT00011791 | Completed | Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia |
|
Observational |
|
NIH | 61 | All | 9 Years to 40 Years (Child, Adult) | NCT00011791 | 010096 01-CH-0096 |
February 22, 2001 | May 10, 2011 | March 1, 2001 | July 2, 2017 |
|
|||||||
23 | NCT02795871 | Recruiting | Prenatal Dex Study |
|
|
Interventional | Not Applicable |
|
Other |
|
|
500 | All | 6 Years to 15 Years (Child) | NCT02795871 | 69HCL14_0447 | Prenatal Dex | October 2016 | December 2018 | December 2019 | June 10, 2016 | February 23, 2017 |
|
|
24 | NCT00001521 | Completed | Three Drug Combination Therapy Versus Conventional Treatment of Children With Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 1 |
|
NIH |
|
62 | All | 2 Years to 20 Years (Child, Adult) | NCT00001521 | 960033 96-CH-0033 |
February 2, 1996 | January 11, 2017 | November 4, 1999 | April 24, 2018 |
|
||||
25 | NCT03062280 | Recruiting | A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
110 | All | 18 Years and older (Adult, Senior) | NCT03062280 | DIUR-006 | August 18, 2016 | August 2018 | August 2018 | February 23, 2017 | July 19, 2017 |
|
||
26 | NCT00000102 | Completed | Congenital Adrenal Hyperplasia: Calcium Channels as Therapeutic Targets |
|
|
Interventional | Phase 1 Phase 2 |
|
NIH |
|
All | 14 Years to 35 Years (Child, Adult) | NCT00000102 | NCRR-M01RR01070-0506 M01RR001070 |
November 4, 1999 | June 24, 2005 |
|
|||||||
27 | NCT00519818 | Completed Has Results |
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 1 Phase 2 |
|
Industry / NIH |
|
|
20 | All | 16 Years to 60 Years (Child, Adult) | NCT00519818 | 070211 | August 2007 | May 2009 | May 2009 | August 23, 2007 | March 24, 2016 | August 27, 2014 |
|
|
28 | NCT01859312 | Completed Has Results |
Comparison of Cortisol Pump With Standard Treatment for Congenital Adrenal Hyperplasia |
|
|
Interventional | Phase 2 |
|
NIH |
|
|
8 | All | 18 Years to 99 Years (Adult, Senior) | NCT01859312 | 130121 13-CH-0121 |
May 6, 2013 | December 2, 2016 | December 2, 2016 | May 21, 2013 | December 22, 2017 | November 22, 2017 |
|
|
29 | NCT01313455 | Completed | Adrenal Hyperplasia Among Young People With PCOS |
|
Observational |
|
NIH |
|
96 | Female | 16 Years to 29 Years (Child, Adult) | NCT01313455 | 110119 11-CH-0119 |
March 10, 2011 | October 24, 2017 | March 11, 2011 | October 26, 2017 |
|
||||||
30 | NCT01184651 | Completed | Tweens to Teens Project at Penn State |
|
|
Observational |
|
Other / NIH |
|
188 | Female | 10 Years to 13 Years (Child) | NCT01184651 | PSU ORP#30695 1R01HD057930-01A1 |
T2T@PSU | August 2009 | July 2013 | July 2013 | August 19, 2010 | January 8, 2018 |
|
|||
31 | NCT02810496 | Recruiting | Mutations of Glucocorticoid Receptor in Bilateral Adrenal Hyperplasia |
|
|
Interventional | Not Applicable |
|
Other |
|
|
150 | All | 18 Years and older (Adult, Senior) | NCT02810496 | PN11010 | MUTA-GR | April 2012 | December 2016 | June 23, 2016 | June 23, 2016 |
|
||
32 | NCT01735617 | Completed Has Results |
Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH |
|
|
Interventional | Phase 2 |
|
Industry / NIH |
|
|
16 | All | 18 Years and older (Adult, Senior) | NCT01735617 | DIUR-003 | December 2012 | December 2013 | December 2013 | November 28, 2012 | May 17, 2017 | May 17, 2017 |
|
|
33 | NCT03019614 | Completed | An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
30 | Male | 18 Years to 60 Years (Adult) | NCT03019614 | DIUR-001 | March 2010 | April 2010 | April 2010 | January 12, 2017 | January 12, 2017 | |||
34 | NCT03051893 | Completed | A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations |
|
|
Interventional | Phase 1 |
|
Industry |
|
|
28 | Male | 18 Years to 60 Years (Adult) | NCT03051893 | DIUR-002 | February 2011 | April 2012 | April 2012 | February 14, 2017 | February 14, 2017 | |||
35 | NCT01488721 | Completed | Clinical Evaluation of NeoPlex4 Assay and NeoPlex System |
|
Observational |
|
Industry |
|
7462 | All | up to 7 Days (Child) | NCT01488721 | CLD-0001 | December 2011 | February 2012 | April 2012 | December 8, 2011 | August 17, 2012 |
|
|||||
36 | NCT00250159 | Enrolling by invitation | Natural History Study of Patients With Excess Androgen |
|
Observational |
|
NIH |
|
|
741 | All | up to 80 Years (Child, Adult, Senior) | NCT00250159 | 060011 06-CH-0011 |
November 3, 2005 | November 7, 2005 | April 19, 2018 |
|
||||||
37 | NCT00172510 | Unknown † | Mutation Analysis of 17α-Hydroxylase |
|
|
Observational |
|
Other |
|
25 | All | Child, Adult, Senior | NCT00172510 | 9361701060 | August 2004 | August 2005 | September 15, 2005 | September 15, 2005 |
|
|||||
38 | NCT03174847 | Recruiting | Prospective Study Assessing Blood Pressure and Other Outcomes Post-treatment in Patients With Primary Aldosteronism |
|
|
Observational |
|
Other |
|
|
50 | All | 21 Years to 80 Years (Adult, Senior) | NCT03174847 | PA_PACES CHF2016.02-P |
PA_PACES | February 20, 2017 | January 30, 2019 | January 30, 2020 | June 5, 2017 | June 5, 2017 |
|
||
39 | NCT01875640 | Completed | Decision Support for Parents Receiving Information About Child's Rare Disease |
|
Observational |
|
Other |
|
|
63 | All | Child, Adult, Senior | NCT01875640 | 1360 13-PAF00134 HUM72007 |
DSD DST | June 2013 | May 2016 | December 2017 | June 12, 2013 | February 20, 2018 |
|
|||
40 | NCT02733367 | Active, not recruiting | Extension Study for Patients Entered Into Study Infacort 003 |
|
|
Interventional | Phase 3 |
|
Industry |
|
|
24 | All | up to 6 Years (Child) | NCT02733367 | Infacort 004 | March 4, 2016 | August 2018 | August 2018 | April 11, 2016 | November 9, 2017 |
|
||
41 | NCT02934399 | Recruiting | Dynamic Hormone Diagnostics in Endocrine Disease |
|
|
Observational |
|
Other |
|
|
350 | All | 18 Years to 68 Years (Adult, Senior) | NCT02934399 | REKno 2015/872 | ultradian | October 2016 | September 2019 | September 2019 | October 17, 2016 | February 23, 2018 |
|
||
42 | NCT00485186 | Withdrawn | Gene Polymorphisms Influencing Steroid Synthesis and Action |
|
Observational |
|
Other |
|
0 | All | Child, Adult, Senior | NCT00485186 | D429/05 | June 2007 | June 2013 | June 2013 | June 12, 2007 | September 5, 2013 | ||||||
43 | NCT01567111 | Active, not recruiting | 11C-Metomidate PET Versus Adrenal Vein Sampling in Primary Aldosteronism |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | All | 20 Years to 65 Years (Adult) | NCT01567111 | T79/2011 | MIA | February 2012 | August 2015 | December 2022 | March 30, 2012 | March 1, 2017 |
|
|
44 | NCT03188640 | Completed | Bariatric Surgery, Hormones, and Quality of Life |
|
|
Interventional | Not Applicable |
|
Other |
|
|
68 | Female | 18 Years to 50 Years (Adult) | NCT03188640 | 2012/392-31 | OBLIV | March 1, 2014 | October 31, 2016 | October 31, 2016 | June 15, 2017 | June 16, 2017 | ||
45 | NCT01661387 | Recruiting | A European Post-Authorisation Observational Study (Registry) of Patients With Chronic Adrenal Insufficiency (AI) |
|
Observational |
|
Industry |
|
|
3000 | All | Child, Adult, Senior | NCT01661387 | Protocol 0918-400 | August 2012 | August 2019 | August 2019 | August 9, 2012 | January 27, 2017 |
|
||||
46 | NCT01234220 | Completed | Adrenal Vein Sampling International Study (AVIS Study) |
|
Observational |
|
Other |
|
|
2604 | All | 18 Years and older (Adult, Senior) | NCT01234220 | GPR-AVIS | AVIS | May 2010 | June 2011 | November 2011 | November 4, 2010 | January 15, 2013 |
|
|||
47 | NCT02155933 | Recruiting | Assessment of Day-night Secretion of Progesterone and LH Across Puberty |
|
|
Observational |
|
Other / NIH |
|
|
75 | Female | 7 Years to 17 Years (Child) | NCT02155933 | 13502 P50HD028934 |
LH | February 2008 | February 2019 | February 2019 | June 4, 2014 | April 12, 2018 |
|
||
48 | NCT03252223 | Recruiting | Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS |
|
|
Interventional | Phase 4 |
|
Other |
|
|
42 | Female | 18 Years to 37 Years (Adult) | NCT03252223 | 170684 | October 2, 2017 | August 31, 2019 | October 1, 2019 | August 17, 2017 | September 26, 2017 |
|
||
49 | NCT03088046 | Completed | Circulating Androgen Levels Are Not Affected by the Administration of Vaginal Micronized Progesterone for Withdrawal Bleeding in Patients With Polycystic Ovarian Syndrome |
|
|
Interventional | Not Applicable |
|
Other |
|
|
15 | Female | 18 Years to 35 Years (Adult) | NCT03088046 | SMD-2017-02 | February 2014 | February 2015 | February 2015 | March 23, 2017 | March 23, 2017 | |||
50 | NCT02651636 | Completed | Combined Therapy With Myo-inositol and Alpha-Lipoic Acid in PCOS Women |
|
|
Interventional | Not Applicable |
|
Other |
|
|
40 | Female | 18 Years to 35 Years (Adult) | NCT02651636 | 000102014 | June 2014 | July 2015 | January 11, 2016 | January 11, 2016 |
† Study has passed its completion date and status has not been verified in more than two years.